
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Immunol. , 23 April 2018
Sec. Cancer Immunity and Immunotherapy
Volume 9 - 2018 | https://doi.org/10.3389/fimmu.2018.00824
A retraction of this article was approved in:
Retraction: Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells
Citation: Zhu L, Oh JM, Gangadaran P, Kalimuthu S, Baek SH, Jeong SY, Lee S-W, Lee J and Ahn B-C (2018) Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells. Front. Immunol. 9:824. doi: 10.3389/fimmu.2018.00824
Received: 14 August 2017; Accepted: 04 April 2018;
Published: 23 April 2018; Retracted: 16 July 2019.
Edited by:
Anahid Jewett, University of California, Los Angeles, United StatesReviewed by:
Eliana Ruggiero, San Raffaele Hospital (IRCCS), ItalyDisclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.